Full name
PROTERAPIA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
10.89.Z - Production of other food products, not elsewhere classified
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46 - Wholesale trade
46.46.Z - Wholesale trade of pharmaceutical and medical products
47 - Retail trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
52.10 - Warehousing and storage of goods
70.2 - Business and management consultancy activities
72 - Scientific research and development activities
73.1 - Advertising
78 - Employment activities
85.5 - Non-school forms of education
2022 | 2023 | 2024 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 21,1 | 19,8 | 19,7 | -0,5 |
EBITDA | 21,1 | 19,8 | 19,8 | 0,1 |
Short time liabilities | 7,8 | 7,8 | 7,8 | -0,1 |
Equity capital | 68,4 | 67,2 | 67,1 | -0,1 |
Operating profit (EBIT) | 21,1 | 19,8 | 19,8 | 0,1 |
Assets | 76,2 | 75 | 74,9 | -0,1 |
Net profit (loss) | 19,2 | 18 | 17,9 | -0,6 |
Cash | 65,3 | 45,3 | 62,2 | 37,2 |
Net income from sale | 189,7 | 254,6 | 293,3 | 15,2 |
Liabilities and provisions for liabilities | 7,8 | 7,8 | 7,8 | -0,1 |
Working assets | 76,2 | 75 | 74,9 | -0,1 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 28,1 | 26,8 | 26,7 | -0,1 |
Equity capital to total assets | 89,8 | 89,6 | 89,6 | 0 |
Gross profit margin | 11,1 | 7,8 | 6,7 | -1,1 |
EBITDA Margin | 11,1 | 7,8 | 6,8 | -1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 15 | 11 | 10 | -1 |
Current financial liquidity indicator | 9.759389877319336 | 9.604836463928223 | 9.600736618041992 | 0 |
Net dept to EBITDA | -3.093153238296509 | -2.289729356765747 | -3.137155294418335 | -0,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane